CC
Chemours Co
NYSE · Basic Materials · Chemicals - Specialty · US
$14.58
−2.99%Price chart
Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9Sep 14
ValuationView details →
P/E (Fwd)
9.5x
EV/EBITDA
−34.0x
Market Cap
$2.19B
MomentumView details →
1D Return
−2.99%
YTD Return
+25.15%
RSI (14)
38.9
ValuationView details →
P/E (Fwd)
9.5x
EV/EBITDA
−34.0x
Market Cap
$2.19B
RSI (14)
38.9
MomentumView details →
1D Return
−2.99%
YTD Return
+25.15%
SummaryUpdated Jun 1, 2026
The Chemours Company (NYSE:CC) is a specialty chemicals manufacturer that was spun off from DuPont in 2015. Founded in 2014 and headquartered in Wilmington, Delaware, Chemours operates as an independent company focused on performance chemicals across diverse industrial and consumer applications. The company has evolved from its DuPont heritage to become a focused specialty chemicals provider, though it has faced significant challenges including legacy environmental liabilities, market cyclicality, and high debt levels stemming from its spinoff structure.
Similar companies
Latest newsMore news →
Veolia filed a lawsuit in Delaware Superior Court against nine alleged PFAS makers, distributors or users, seeking at least $34.6 million to recover the cost of filtering PFAS from its drinking water system serving about 40,000 customers in New Castle County, Delaware.3d agoThe Chemours Co signed a settlement agreement to pay $455 million over 15 years to resolve PFAS and other emissions claims related to its Fayetteville Works facility brought by North Carolina counties and the State of North Carolina.5d agoA class action lawsuit against Chemours and DuPont over PFAS contamination in the Cape Fear River will go to jury trial in March 2027, after a judge granted partial summary judgment for trespass liability.7d ago